ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2020

Approval of Itolizumab for COVID-19: A Premature Decision or Need of The Hour?

Shubham Atal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.